AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
Go back to AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies| (NASDAQ: ANAB) | Delayed: 66.09 -0.5 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.59 | 52 Week High | $ | |||
| Open | $66.55 | 52 Week Low | $ | |||
| Day High | $68.33 | P/E | N/A | |||
| Day Low | $63.50 | EPS | $ | |||
| Volume | 191,935 | |||||

